Background: Prolonged use of antibiotics may lead to the selection of drug-resistant bacteria; as a result, efforts are being made to identify new and effective antimicrobial agents, particularly, from medicinal plants, against bacterial infections. Antimicrobial activity of Gymnosperma glutinosum against Helicobacter pylori has not yet been reported.
Introduction
Helicobacter pylori (H. pylori) is a Gram-negative spiral-shaped bacteria, which is the main factor for the development of duodenal ulcer disease and has been involved in the development of gastric ulcer, which increases the risk of stomach cancer, the most common digestive tract neoplasia worldwide (Arana y Corona, 2009 ). In developed countries, 70 to 90% of the population becomes infected before 10 years of age and the modes of transmission include oral-oral or fecal-oral, and iatrogenic when performing endoscopy with a contaminated tube from person to person (Dunn et al., 1997) . In addition to surgery, including partial gastrectomy, a variety of antibiotics approved by the United States Food and Drug Administration to treat gastric ulcer have been suggested, among which it is common the use of bismuth subsalicylate, metronidazole, and tetracycline, in addition to an antacid agent; however, this can cause systemic damage such as pseudo-membranous colitis (11%) and vaginal candidiasis (above 10%) in women under treatment (Dunn et al., 1997) .
H. pylori infections are currently treated with antibiotics, plant extracts, and various types of immunization with the aim of preventing the colonization of the bacterium, as well as eradicate it when it is established in gastric epithelial cells. Different antibiotics have been suggested to treat H. pylori; among these, the use of 10 to 14 days of 20 mg omeprazole twice daily or using plus amoxicillin 1g, 2 times per day, can remove 80 to 90% of these bacteria (Ramakrishnan et al., 2007 ). An antibiotic scheme 7 days in patients infected with H. pylori on the basis of 400 mg of ranitidine, metronidazole 500 mg, and 500 mg of clarithromycin was used before meals in another study, in which they found elimination of the bacteria in 91% of 47 patients (Hoffman et al., 1999) .
There is a general warning about the potential benefits of medicinal plants for health, as part of complementary medicine in the world (Gomez-Flores et al., 2010 ). Plants play a vital role in the medicinal practices of many Native Americans who use them not only for diagnosis and treatment, such as Ginseng (Panax quinquefolius, Panax ginseng, Eleutherococcus senticosus), Echinacea (Echinacea purpurea, Echinacea angustifolia, Echinacea pallida), and Goldenseal (Hydrastis canadensis), but also to enhance immune responses against many diseases (Borchers et al., 2000) . Interest in botanical medicine has increased over the years, not only by physicians, but also by public in general who seem to prefer natural products than synthetic ones (Borchers et The present study was designed to evaluate the effects of the Gymnosperma glutinosum leaf extracts on H. pylori growth. The plant belongs to the family Asteraceae, but has not been previously reported to have antimicrobial activity against this bacterium. We found significant in vitro growth inhibition activity of G. glutinosum extracts against H. pylori.
Material and Methods
Reagents, culture medium, and bacterial strain 
Plant extract preparation
Gymnosperma glutinosum (Spreng.) Less. was collected in Escobedo, NL, México and identified by Biol. Ma. del Consuelo González from Facultad de Ciencias Biológicas Herbarium at Universidad Autónoma de Nuevo León, México, with the specimen voucher number 024784. Leaves were washed, dried, and macerated. To prepare aqueous extracts, 5 grams of leaves powder were allowed to stand in boiling water (80ml) for 10 minutes, freeze dried (Freeze Dry Systems, Labconco Corporation, KC) and stored at -20ºC, until use. To produce methanol extracts, 5 grams of leaves powder were allowed to stand in 100% methanol (80ml) for 24 hours at room temperature, solution was then dried in a Speed Vac (Milford.MA) and stored at 6ºC, until use. Aqueous and methanol extracts were then diluted to 1mg/ml in sterile media. Under aseptic conditions, the products were then filtrated through 0.22µ-pore size diameter filters (Whatman filters, Whatman International Ltd., Maidstone, England) and one milliliter aliquots were stored in 1.5ml Eppendorf tubes at -20°.
Plant extracts susceptibility testing
In brief, 50 µl of H. pylori suspensions at 2.5 x 10 5 bacteria/mL were plated in Brucella broth (Difco), in flat-bottomed 96-well plates (Corning Incorporated, Corning, NY), in the presence or absence of serial dilutions (1:2) of the G. glutinosum aqueous or methanol extract (50 µl) at 1mg/ml, and 50µl antibiotic control (tetracycline), methanol vehicle control or culture medium. The methanol vehicle control was similarly processed as with plant methanol extractions, but without plant material. Plates were then incubated for 6 h at 37°C, after which the tetrazolium salt MTT was added to all wells at a final concentration of 0.5 mg/ml, and plates were incubated for 15 additional minutes. At the end of the incubation period, 80 µl of DMSO were added to all wells and plates were incubated for 15 minutes. Optical densities resulting from dissolved formazan crystals were then read in a microplate reader (DTX 880 Multimode detector, Becton Dickinson, Austria) a 570 nm , 2010 Caballero-Hernandez et al., 2009 ). In regard to CFUs determination, 50 µl of the microbial suspensions were plated in Brucella broth, in flat-bottomed 96-well plates (Corning Incorporated), in the presence or absence of serial dilutions (1:2) of the G. glutinosum aqueous or methanol extract (50 µl), antibiotic control (5 μg/ml tetracycline), and vehicle controls (methanol and culture medium). Then, 1:10,000 dilutions were prepared from the wells and 100 µl were plated on Brucella agar plates (Difco). Agar plates were then incubated at 37 o C for 24h and colonies were counted in a colony counter (ULB-100, Lightbox 37864-2000, Scienceware BEL-ART products, Pequannock, NJ). Percent growth inhibition was calculated as follows: 
Results
G. glutinosum aqueous extract did not alter H. pylori growth (data not shown), however, methanol extract showed minimal inhibitory concentration (MIC) of 31.25µg/ml and 250 µg/ml and induced a maximum of 82% and 100% growth inhibition against H. pylori, as measured by the MTT reduction assay and CFU method, respectively (Fig. 1) . Methanol extract caused from 24% to 82% significant (p<0.05) H. pylori growth inhibition at concentrations from 31.25 µg/ml to 500 µg/ml, respectively, as measured by the MTT reduction assay, and significant (p<0.05) 52% and 100% growth inhibition at concentrations of 250µg/ml and 500µg/ml, respectively, as measured by the CFU method (Fig. 1 ). Methanol vehicle control or medium alone did not alter bacterial growth (data not shown). 
Conclusion
To our knowledge, this is the first report showing that G. glutinosum methanol extracts inhibit H. pylori growth in-vitro. There are still a number of plant compounds that remain to be evaluated at the molecular, cellular, and physiological levels for their potential to treat human diseases.
